Gsk (GSK) Dividend Yield (2026)
Gsk (GSK) posted Dividend Yield of 4.2% for Q3 2026, up 75.67% quarter-over-quarter from 2.39% in Q1 2026.
Analysis
Gsk (GSK) Dividend Yield (2026) Analysis & Trends
Gsk (GSK) has 18 years of Dividend Yield data on file, last reported at 4.2% in Q3 2026.
- For the quarter ending Q3 2026, Dividend Yield changed N/A year-over-year to 4.2%; the trailing twelve-month figure through Sep 2026 stood at 4.2% (changed N/A YoY), and the FY2025 full-year result was 3.22%, down 106.0% from the prior year.
- Dividend Yield was 4.2% for Q3 2026 at Gsk, up from 2.39% in the prior quarter.
- In the past five years, Dividend Yield ranged from a high of 7.06% in Q3 2022 to a low of 2.39% in Q1 2026.
- A 5-year average of 3.78% and a median of 3.31% in 2024 frame the typical range for Dividend Yield.
- The largest YoY upside for Dividend Yield was 180 bps in 2022 against a maximum downside of 491 bps in 2022.
- Gsk's Dividend Yield stood at 5.45% in 2022, then sank by 47 bps to 2.88% in 2023, then climbed by 21 bps to 3.47% in 2024, then slipped by 25 bps to 2.6% in 2025, then jumped by 62 bps to 4.2% in 2026.
- Per Business Quant data, the three most recent Dividend Yield figures were 4.2% in Q3 2026, 2.39% in Q1 2026, and 2.6% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn |